{"slug":"oxford-biotherapeutics","name":"Oxford BioTherapeutics","url":"https://www.gp-intel.com/company/oxford-biotherapeutics","sector":null,"country":"United Kingdom","hq_city":null,"website":null,"founded_year":null,"ipo_year":null,"status":"pe_owned","current_owner":"ALSA Ventures","current_holder":{"name":"ALSA Ventures and Oxford Capital","names":["ALSA Ventures","Oxford Capital"],"since_year":2019,"basis":"active_investor"},"ownership_periods":2,"ownership":[{"owner":"ALSA Ventures","fund":"ALSA Ventures European Biotechnology Fund","fund_vintage":2020,"entry_year":2019,"exit_year":null,"is_exit":false,"deal_type":null,"buyer":null,"moic":null,"sector":null},{"owner":"Oxford Capital","fund":"Oxford Capital Growth EIS","fund_vintage":1999,"entry_year":null,"exit_year":null,"is_exit":false,"deal_type":null,"buyer":null,"moic":null,"sector":null}],"source":"gp-intel.com","license":"CC-BY-4.0","updated_at":"2026-09-29T11:18:35.152Z"}